A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults. Researchers found that low ApoM impairs cholesterol metabolism in the retina, contributing to inflammation and vision loss—especially in advanced forms like geographic atrophy.
